Ash 2024 Hematology/Oncology. At ash, abbvie will present the latest data for investigational and approved blood cancer therapies including: The ash meeting on hematologic malignancies features the top experts in the field, comprehensive clinical content in each of the core hematologic malignancies, and.
At ash, abbvie will present the latest data for investigational and approved blood cancer therapies including: *schedule is subject to change.
